Yes, GPCRs are major targets for drug therapy. Many medications are designed to either activate or inhibit GPCRs. In toxicology, understanding GPCR-targeted drugs is crucial for predicting adverse drug reactions and interactions. For example, beta-blockers are antagonists of adrenergic receptors and are used to manage hypertension but can cause adverse effects in overdose situations.
